LYN-00204

N/A

Report date: 2022/02/11 16:04:17
NME

Base Information

Drug NameLYN-00204
Drug Alias NameLYN-00204
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitorsSerine/threonine-protein kinase B-raf inhibitors
Targets3',5'-cyclic phosphodiesteraseSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLynkcell Inc
China Registration ClassN/A

Develop Information

Active CompaniesLynkcell Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A